However, PD-L1 expression is elevated in many types of malignancies, and the PD-1/PD-L1 axis is hijacked by tumor cells in the TME to evade immune surveillance, thereby facilitating tumor immune escape.98 This evidence concerns the gene CD274 and neoplasm.